You just read:

Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion

News provided by

Regeneron Pharmaceuticals, Inc.

Apr 27, 2011, 04:05 ET